Exane Derivatives’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$1.6M Sell
43,067
-2,859
-6% -$107K 0.92% 21
2022
Q1
$2.03M Sell
45,926
-3,459
-7% -$153K 0.57% 33
2021
Q4
$2.1M Sell
49,385
-47,037
-49% -$2M 0.51% 36
2021
Q3
$4.18M Sell
96,422
-3,695
-4% -$160K 1% 13
2021
Q2
$4.31M Buy
100,117
+7,755
+8% +$334K 0.98% 16
2021
Q1
$3.57M Sell
92,362
-16,414
-15% -$634K 1.02% 18
2020
Q4
$3.91M Buy
108,776
+11,024
+11% +$396K 1.15% 16
2020
Q3
$3.74M Sell
97,752
-19,354
-17% -$740K 1.08% 19
2020
Q2
$4.11M Sell
117,106
-1,628
-1% -$57.2K 1.1% 20
2020
Q1
$3.87M Buy
118,734
+40,954
+53% +$1.34M 1.08% 20
2019
Q4
$3.31M Buy
77,780
+35,416
+84% +$1.51M 0.61% 56
2019
Q3
$1.72M Sell
42,364
-1,598
-4% -$65K 0.31% 71
2019
Q2
$1.89M Buy
43,962
+9,479
+27% +$407K 0.33% 67
2019
Q1
$1.32M Buy
34,483
+33,319
+2,862% +$1.28M 0.26% 83
2018
Q4
$41.1K Buy
1,164
+1,163
+116,300% +$41.1K 0.01% 344
2018
Q3
$39 Sell
1
-406
-100% -$15.8K ﹤0.01% 610
2018
Q2
$13.3K Sell
407
-1,802
-82% -$58.7K ﹤0.01% 416
2018
Q1
$59K Sell
2,209
-534
-19% -$14.3K 0.01% 324
2017
Q4
$68.1K Buy
2,743
+2,720
+11,826% +$67.5K 0.01% 290
2017
Q3
$671 Sell
23
-127
-85% -$3.71K ﹤0.01% 425
2017
Q2
$4.16K Sell
150
-1,538
-91% -$42.6K ﹤0.01% 399
2017
Q1
$42K Sell
1,688
-2,112
-56% -$52.5K 0.01% 256
2016
Q4
$82.2K Buy
+3,800
New +$82.2K 0.02% 234
2015
Q4
Sell
-2,523
Closed -$41.4K 482
2015
Q3
$41.4K Buy
+2,523
New +$41.4K 0.01% 245